VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 295 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2018. The put-call ratio across all filers is 2.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $2,438,000 | +4.8% | 153,200 | +36.8% | 0.04% | +23.5% |
Q4 2017 | $2,327,000 | +282.1% | 112,000 | +166.7% | 0.03% | +126.7% |
Q4 2016 | $609,000 | -82.8% | 42,000 | -70.9% | 0.02% | -87.2% |
Q3 2016 | $3,547,000 | -78.1% | 144,500 | -82.0% | 0.12% | -84.5% |
Q2 2016 | $16,186,000 | -37.3% | 803,700 | -18.1% | 0.76% | -39.5% |
Q1 2016 | $25,823,000 | +199.6% | 981,900 | +2162.4% | 1.25% | +50.7% |
Q1 2015 | $8,620,000 | +452.9% | 43,400 | +298.2% | 0.83% | +245.0% |
Q4 2014 | $1,559,000 | -32.9% | 10,900 | -38.4% | 0.24% | -46.4% |
Q3 2014 | $2,322,000 | +40.3% | 17,700 | +25.5% | 0.45% | +181.8% |
Q4 2013 | $1,655,000 | – | 14,100 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |